When will Compass Pathways submit a NDA for COMP360 psilocybin?
Health & MedicineOne-OffWetenschapBusiness & Corporate1mnd
KalshiBeschikbaarheid controlerenKYC vereist2% kostenGeverifieerde afwikkelingsgegevensGrof gekalibreerdHuidige impliciete kansbefore September 15%Koploper van 6 uitkomsten
Marktkwaliteit
40 / 100
Lage kwaliteit24u volume
€ 0
Liquiditeit
€ 4,2K
Gemiddelde liquiditeitBied / Laat
9.0% / 12.0%
Spread
33.3%
Brede spreadMarktdata
Bijgewerkt 8 minuten geleden
24 mrt 26, 14:001 sep 26, 14:00
Trends
Alleen virtueel geld, geen echt geldGeen financieel advies
Gekozen uitkomst
before September15%
Volumetrend
$12 jul19d aan data25 jul
Gerelateerde Markten
Which fast food chain in the USA will offer a lab-grown / cultivated meat product first?
€ 108,5Mc Donald's: 7%MANIFOLD MARKETS
MANIFOLD MARKETS
When will I be able to buy cultured meat at a random Whole Foods?
€ 219,82024: 0.6%MANIFOLD MARKETS
MANIFOLD MARKETSTestosterone unscheduled/rescheduled more permissively in US by end of 2028?
€ 511,3Ja: 17.8%MANIFOLD MARKETS
MANIFOLD MARKETS
When will Intellia Therapeutics submit a BLA for Lonvo-z?
€ 56,1before 2027: 78%KALSHI
KALSHI
Hantavirus vaccine in 2026?
€ 2,8Ja: 6%
POLYMARKET
POLYMARKET
Will there be a year without polio before 2030?
€ 0Ja: 11%KALSHI
KALSHIActief in deze onderwerpen
Gerelateerd Nieuws
LMAX taps Morgan Stanley to weigh $5B sale or Nasdaq listingCrypto News
Institutional crypto trading platform LMAX is exploring sale, IPOCoindesk
BitMine Adds $73 Million in ETH, Pushing Holdings to 4.8% of SupplyThe Defiant
Turtle Acquires Lunar Strategy to Combine Capital and Attention Into One StackBlockchain Reporter
Bitcoin treasury companies sell up, repay debt, pivot to AI as share prices collapseCoindesk
Ripple targets $2 trillion payment network with Notabene dealCrypto NewsRegels
If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Oct 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Dec 1, 2026, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes.
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.